AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol (September 21, 2001). doi:10.1152/ajprenal.00087.2001
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/2/F238    most recent
00087.2001v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nishiyama, A.
Right arrow Articles by Abe, Y.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Nishiyama, A.
Right arrow Articles by Abe, Y.

Articles in PresS, published online ahead of print September 20, 2001
Am J Physiol Renal Physiol, 10.1152/ajprenal.00087.2001
Submitted on March 15, 2001
Accepted on September 5, 2001

Blood flow-dependent changes in renal interstitial cyclic guanosine 3',5'-monophosphate in rabbits

Akira Nishiyama1*, Shoji Kimura1, Toshiki Fukui1, Matlubur Rahman1, Hirohito Yoneyama2, Hiroaki Kosaka2, and Youichi Abe1

1 Pharmacology, Kagawa Medical University, Kagawa, Kagawa, Japan
2 Physiology, Kagawa Medical University, Kagawa, Kagawa, Japan

* To whom correspondence should be addressed. E-mail: yakuri{at}kms.ac.jp.

We have evaluated the responses of renal interstitial cyclic guanosine 3',5'-monophosphate (cGMP) to changes in renal arterial pressure (RPP) within and below the range of renal blood flow (RBF) autoregulation. Using an in vivo microdialysis method, renal cortical and medullary interstitial cGMP levels were monitored in anesthetized rabbits. RPP was reduced in 2 steps, one from the ambient pressure (89±3 mmHg) to 70±2 mmHg (Step-1) and then to 48±3 mmHg (Step-2). RBF was maintained in Step-1 but was significantly decreased in Step-2 from 2.94±0.23 to 1.47±0.08 mL/min-1/g-1. The basal interstitial concentrations of cGMP and nitrate/nitrite in the cortex (12.1±1.4 nmol/L and 41±2 µmol/L, respectively) were significantly lower than those in the medulla (19.9±0.4 nmol/L and 62±5 µmol/L, respectively). Renal interstitial concentrations of cGMP in the cortex and medulla did not change in Step-1, but these levels were significantly decreased in Step-2 with the magnitude of reductions in cGMP concentrations in the medulla (-25±3%) being significantly less than those in the cortex (-44±3%). Over this pressure range, changes in cortical and medullary interstitial concentrations of cGMP were highly correlated with changes in RBF (cortex, r=0.94, P<0.005; medulla, r=0.82, P<0.01). Cortical and medullary interstitial concentrations of nitrate/nitrite were not changed in Step-1, but were significantly decreased in Step-2 (cortex, -38±2%; medulla, -20±2%). Nitric oxide (NO) synthase inhibition with NG-nitro-L-arginine methyl ester (L-NAME: 30 mg/kg-1, bolus and 50 mg/kg-1/h-1, infusion for 60-min, i.v.) significantly decreased RBF (by -46±4%) and interstitial concentrations of cGMP (cortex, -27±4%; medulla, -22±4%, respectively). Although basal RBF levels were reduced by L-NAME, equally efficient autoregulation was observed in response to reductions in RPP. During L-NAME treatment, renal interstitial concentrations of cGMP in the cortex and medulla were similarly not altered in Step-1. However, L-NAME significantly attenuated cGMP responses to a reduction in RPP in Step-2 (cortex, -20±3%; medulla, -14±3%). These results indicate that acute changes in RBF result in alterations in NO-dependent renal interstitial cGMP levels, with differential effects in the medulla compared to the cortex.




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
A. Nishiyama, M. Yoshizumi, H. Hitomi, S. Kagami, S. Kondo, A. Miyatake, M. Fukunaga, T. Tamaki, H. Kiyomoto, M. Kohno, et al.
The SOD Mimetic Tempol Ameliorates Glomerular Injury and Reduces Mitogen-Activated Protein Kinase Activity in Dahl Salt-Sensitive Rats
J. Am. Soc. Nephrol., February 1, 2004; 15(2): 306 - 315.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. B. Brosnihan, L. A.A. Neves, J. Joyner, D. B. Averill, M. C. Chappell, R. Sarao, J. Penninger, and C. M. Ferrario
Enhanced Renal Immunocytochemical Expression of ANG-(1-7) and ACE2 During Pregnancy
Hypertension, October 1, 2003; 42(4): 749 - 753.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1976 by the American Physiological Society.